Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

WWII and the evolution of US federal research funding.

Science (New York, N.Y.)·2026
Same author

Analysis of AI-Generated Radiography Responses Using a Closed-System LLM.

Radiologic technology·2026
Same author

Verifying Outputs in Scopus AI to Promote Critical AI Literacy in Education and Research.

Radiologic technology·2026
Same author

Active guidance in ultrasound bladder scanning using reinforcement learning.

Scientific reports·2026
Same author

A Practical Guide for Using Generative AI in Academic Research.

Radiologic technology·2026
Same author

Comment on Comparative Analysis of LLMs' Performance on a Practice Radiography Certification Exam.

Radiologic technology·2026

Related Experiment Video

Updated: May 3, 2026

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

9.8K

Small-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification.

Maureen H Beresini1, Yichin Liu1, Timothy D Dawes1

  • 1Department of Biochemical & Cellular Pharmacology, Genentech Inc, South San Francisco, CA, USA.

Journal of Biomolecular Screening
|February 13, 2014
PubMed
Summary

Creating focused compound library subsets enhances drug discovery. These diverse sets, including validation, diversity, and property-restricted libraries, improve hit identification and accelerate lead discovery processes.

Keywords:
compound libraryhigh-throughput screeninglibrary subsetmolecular diversity

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

6.4K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K

Related Experiment Videos

Last Updated: May 3, 2026

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

9.8K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

6.4K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Computational Chemistry

Background:

  • Large compound libraries are essential for drug discovery screening.
  • Optimizing library subsets can improve screening efficiency and hit identification.
  • Genentech established multiple focused library subsets to complement its main corporate library.

Purpose of the Study:

  • To establish and validate diverse small-compound library subsets for drug discovery.
  • To assess the utility of these subsets in guiding assay development and predicting hit rates.
  • To identify ligand-efficient compounds using a property-restricted library.

Main Methods:

  • Creation of validation, diversity, and property-restricted (in-between) library subsets.
  • Selection of compounds based on representation of the main library's scaffold diversity.
  • Screening of subsets using computational approaches and internal screening data analysis.
  • Retrospective analysis of hit rates and scaffold recovery.

Main Results:

  • Validation sets confirmed assay reproducibility and provided hit rate estimates.
  • A diversity subset showed similar hit rates to the main library but recovered more unique hit scaffolds.
  • The "in-between library" facilitated the identification of ligand-efficient compounds.

Conclusions:

  • Purpose-focused, diversity-based library subsets accelerate lead discovery.
  • Computational design and data analysis are crucial for optimizing library subsets.
  • Strategic use of library subsets enhances the efficiency and success rate of drug discovery screening.